The EU reached agreement on the Critical Medicines Act aimed at reducing drug shortages by boosting European manufacturing capacity and enabling joint procurement. The package focuses on supply-chain security and diversification rather than lowest-price purchasing, and includes “buy European” incentives alongside fast-track permitting and EU funding for manufacturing buildouts and modernization.